NASDAQ Biotechnology Total Retu XNBI Indice
4501.69 USD
{{ price }}
-2.144341%
{{change_pct}}%
PAESE
stati Uniti
Borsa valori
Nasdaq GIDS
MIN - MAX [24 ore]
4479.13
-
4578.05 USD
Numero di componenti
190
NASDAQ Biotechnology Total Retu Grafico dei prezzi
Top 5 Vincitori delle Ultime 24 Ore
TBPH | Theravance Biopharma | +7.61% | |
---|---|---|---|
PACB | Pacific Biosciences of California | +5.45% | |
KPTI | Karyopharm Therapeutics | +4.42% | |
LIFE | aTyr Pharma | +4.35% | |
RGLS | Regulus Therapeutics | +4.13% |
Top 5 Perdenti delle Ultime 24 Ore
BMRN | BioMarin Pharmaceutical | -9.37% | |
---|---|---|---|
ESPR | Esperion Therapeutics | -7.36% | |
TRVN | Trevena | -7.31% | |
SAGE | Sage Therapeutics | -6.82% | |
DRRX | DURECT | -6.62% |
NASDAQ Biotechnology Total Retu XNBI PANORAMICA FINANZIARIA E DI TRADING
NASDAQ Biotechnology Total Retu Prezzo dell'Indice | 4501.69 USD |
Chiusura Precedente | 4472.96 USD |
Apertura | 4476.26 USD |
Prezzo di Acquisto | 0 USD x 0 |
Prezzo di Vendita | 0 USD x 0 |
Variazione Giornaliera | 4464.53 - 4532.84 USD |
Variazione a 52 Settimane | 4464.53 - 4532.84 USD |
Volume | 0 USD |
Volume Medio | N/A |
Informazioni di trading
NASDAQ Biotechnology Total Retu Storico dei prezzi dell'Indice
Massimo a 52 Settimane | 4532.84 USD |
Minimo a 52 Settimane | 4464.53 USD |
Media Mobile a 50 Giorni | N/A |
Media Mobile a 200 Giorni | N/A |
XNBI Statistiche dell'indice
Volume Medio (3 Mesi) | N/A |
Vol. Medio Giornaliero (10 Giorni) | N/A |
D&R per l'Indice NASDAQ Biotechnology Total Retu
Qual è il prezzo attuale dell'Indice XNBI?
Il prezzo dell'Indice NASDAQ Biotechnology Total Retu XNBI oggi è di 4501.69 USD.
Come acquistare l'Indice NASDAQ Biotechnology Total Retu?
Puoi acquistare l'indice XNBI sulla borsa Nasdaq GIDS. Contatta il tuo consulente finanziario per selezionare un broker.
Qual è la sigla borsistica dell'Indice NASDAQ Biotechnology Total Retu?
La sigla (o ticker) dell'Indice NASDAQ Biotechnology Total Retu è XNBI.
Quanti componenti contiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu contiene 190 componenti.
A quale paese appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento a United States.
A quale borsa appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento alla borsa Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPONENTI
Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
---|
Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
---|---|---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
Amgen AMGN | $273.94 — |
+0.34
|
$143.24B — | $318.33K — | $266.17 — | $269.3 — | $143.24B — | 21.41 | $12.48 — |
Vertex Pharmaceuticals Incorporated VRTX | $402.19 — |
-0.67
|
$102.49B — | $161.92K — | $393.76 — | $400.14 — | $102.49B — | 28.56 | $13.88 — |
Regeneron Pharmaceuticals REGN | $956.84 — |
-0.02
|
$99.3B — | $55.31K — | $898.26 — | $912.22 — | $99.3B — | 26.04 | $34.74 — |
Gilead Sciences GILD | $64.79 — |
+0.02
|
$84.88B — | $582.89K — | $67.62 — | $68.48 — | $84.88B — | 15.12 | $4.5 — |
Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
Biogen BIIB | $194.42 — |
-0.38
|
$28.81B — | $140.43K — | $197.79 — | $205.24 — | $28.81B — | 24.86 | $7.97 — |
Illumina ILMN | $117.5 — |
-0.67
|
$20.24B — | $1.63M — | $126.44 — | $134.85 — | $20.24B — | 0 | -$7.35 — |
Alnylam Pharmaceuticals ALNY | $144.63 — |
-0.99
|
$18.78B — | $90.25K — | $148.28 — | $151.8 — | $18.78B — | 0 | -$3.52 — |
BioMarin Pharmaceutical BMRN | $82.66 — |
-9.37
|
$17.5B — | $6.69M — | $91.09 — | $93.26 — | $17.5B — | 106.00 | $0.87 — |
Neurocrine Biosciences NBIX | $134.66 — |
-0.93
|
$13.54B — | $577.34K — | $134.63 — | $137.78 — | $13.54B — | 54.73 | $2.46 — |
Incyte INCY | $51.34 — |
-0.61
|
$12.09B — | $123.1K — | $53.76 — | $55 — | $12.09B — | 20.32 | $2.65 — |
Sarepta Therapeutics SRPT | $130.81 — |
+1.58
|
$11.53B — | $121.22K — | $121.49 — | $124.82 — | $11.53B — | 0 | -$5.8 — |
United Therapeutics UTHR | $239.27 — |
+2.05
|
$10.95B — | $71.37K — | $232.41 — | $239.32 — | $10.95B — | 11.73 | $19.82 — |
Bio-Techne TECH | $63.5 — |
-0.3
|
$10.49B — | $101.59K — | $66.29 — | $68.52 — | $10.49B — | 48.00 | $1.39 — |
Repligen RGEN | $171.53 — |
-2.58
|
$9.58B — | $706.4K — | $169.74 — | $174.62 — | $9.58B — | 231.79 | $0.74 — |
- {{ link.label }} {{link}}